THE TRIFECTA: A NOVEL COMBINATORIAL THERAPY SPARES IMMUNE CELLS WHILE INDUCING IMMUNOGENIC CELL DEATH IN HUMAN MAMMARY ADENOCARCINOMA AND MOUSE MAMMARY CARCINOMA
According to U.S. Breast Cancer Statistics, about 1 in 8 U.S. women will develop invasive breast cancer during their lifetime. Chemotherapeutics that are used on patients currently often lead to tumor resistance, bone marrow suppression and cachexia. This study evaluated a novel combination of three...
| Other Authors: | |
|---|---|
| Format: | Others |
| Language: | English |
| Published: |
Florida Atlantic University
|
| Subjects: | |
| Online Access: | http://purl.flvc.org/fau/fd/FA00013606 |